Form 10-Q CANCER GENETICS, INC For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cancer Genetics (CGIX) Misses Q2 EPS by 13c
August 14, 2014 7:09 AM EDTCancer Genetics (NASDAQ: CGIX) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $2.13 million.
For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.
... More